MedTrace Logo

AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects

NCT00886756 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2009-08-19

No results posted yet for this study

Summary

This is a Phase I, double-blind, placebo-controlled, randomised within each dose group, single ascending dose study, with the objective to assess the safety, tolerability and pharmacokinetic profile of AZD8529 in healthy Japanese subjects.

Conditions

  • Healthy

Interventions

DRUG

AZD8529

Oral

DRUG

Placebo

Oral

Sponsors & Collaborators

Principal Investigators

  • Ulrike Lorch, MD MFPM FRCA · Richmond Pharmacology Limited

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Completion
2009-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00886756 on ClinicalTrials.gov